Pfizer’s Oporia Is “Not Approvable” For Osteoporosis Prevention
The company says it will consider “various possible courses of action” following FDA’s decision on the selective estrogen receptor modulator.
The company says it will consider “various possible courses of action” following FDA’s decision on the selective estrogen receptor modulator.